Universities of Cologne
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- 251
- Market Cap
- -
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants
Phase 3
Completed
- Conditions
- Nephrocalcinosis
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2012-07-03
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 80
- Registration Number
- NCT00249951
- Locations
- 🇩🇪
Prof. Dr. Bernd Hoppe, Cologne, Germany
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Phase 4
Completed
- Conditions
- PsychosesSchizophrenia
- Interventions
- Behavioral: Supportive management
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-12-24
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 124
- Registration Number
- NCT00204061
- Locations
- 🇩🇪
Department of Psychiatry and Psycotherapy University of Cologne, Cologne, North Rhine-Westphalia, Germany
Psychological Intervention for Persons in the Early Initial Prodromal State
Phase 3
- Conditions
- PsychosisSchizophrenia
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-01-12
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 126
- Registration Number
- NCT00204087
- Locations
- 🇩🇪
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, North Rhine-Westphalia, Germany
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
Phase 3
Terminated
- Conditions
- Leukemia, Myelocytic, Acute
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2006-11-14
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 150
- Registration Number
- NCT00152594
- Locations
- 🇩🇪
Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
🇩🇪Universitätsklinikum Mannheim, Universität Heidelberg, Heidelberg, Germany
🇩🇪Klinikum der Universität Köln, Köln, Germany
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2010-01-27
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 30
- Registration Number
- NCT00147953
- Locations
- 🇩🇪
University of Cologne, Cologne, NRW, Germany
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
Phase 2
Terminated
- Conditions
- Hodgkin Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2008-07-10
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 37
- Registration Number
- NCT00148018
- Locations
- 🇩🇪
University of Cologne, Cologne, NRW, Germany
Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma
Phase 1
Completed
- Conditions
- Hodgkin's Disease
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2009-09-07
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 60
- Registration Number
- NCT00147875
- Locations
- 🇩🇪
University of Cologne, Cologne, NRW, Germany
© Copyright 2025. All Rights Reserved by MedPath